Elevance Health Inc. (0HG8.L)
USD 408.81
(-1.12%)
USD 408.81
(-1.12%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 25.38 USD | 3.35% |
| 2022 | 24.56 USD | -1.92% |
| 2021 | 25.04 USD | 37.36% |
| 2020 | 18.23 USD | -3.08% |
| 2019 | 18.81 USD | 27.53% |
| 2018 | 14.53 USD | -1.73% |
| 2017 | 14.70 USD | 60.36% |
| 2016 | 9.39 USD | -4.49% |
| 2015 | 9.73 USD | 2.3% |
| 2014 | 9.31 USD | 12.84% |
| 2013 | 8.89 USD | -2.53% |
| 2012 | 8.26 USD | 11.67% |
| 2011 | 7.35 USD | 2.09% |
| 2010 | 7.03 USD | -27.58% |
| 2009 | 9.96 USD | 111.0% |
| 2008 | 4.79 USD | -11.35% |
| 2007 | 5.64 USD | 14.4% |
| 2006 | 4.93 USD | 22.33% |
| 2005 | 4.03 USD | 27.94% |
| 2004 | 3.14 USD | 12.5% |
| 2003 | 2.80 USD | 21.21% |
| 2002 | 2.31 USD | 39.16% |
| 2001 | 1.66 USD | 50.91% |
| 2000 | 1.10 USD | 400.0% |
| 1999 | 0.22 USD | -73.81% |
| 1998 | 0.84 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 4.38 USD | -55.98% |
| 2024 Q2 | 9.91 USD | 2.62% |
| 2024 Q1 | 9.65 USD | 162.8% |
| 2023 Q1 | 8.37 USD | 109.99% |
| 2023 Q2 | 7.83 USD | -6.48% |
| 2023 FY | - USD | 3.34% |
| 2023 Q3 | 5.48 USD | -30.05% |
| 2023 Q4 | 3.67 USD | -32.96% |
| 2022 Q2 | 6.80 USD | -8.23% |
| 2022 Q1 | 7.41 USD | 57.66% |
| 2022 Q3 | 6.69 USD | -1.62% |
| 2022 Q4 | 3.99 USD | -40.36% |
| 2022 FY | - USD | -1.92% |
| 2021 Q1 | 6.80 USD | 202.22% |
| 2021 Q2 | 7.33 USD | 7.79% |
| 2021 Q4 | 4.70 USD | -24.19% |
| 2021 Q3 | 6.20 USD | -15.42% |
| 2021 FY | - USD | 37.36% |
| 2020 Q4 | 2.25 USD | 155.68% |
| 2020 Q3 | 0.88 USD | -90.24% |
| 2020 FY | - USD | -3.08% |
| 2020 Q1 | 6.03 USD | 63.41% |
| 2020 Q2 | 9.02 USD | 49.59% |
| 2019 Q3 | 4.64 USD | 4.5% |
| 2019 Q1 | 6.03 USD | 265.45% |
| 2019 Q2 | 4.44 USD | -26.37% |
| 2019 Q4 | 3.69 USD | -20.47% |
| 2019 FY | - USD | 27.53% |
| 2018 Q4 | 1.65 USD | -55.41% |
| 2018 FY | - USD | -1.73% |
| 2018 Q3 | 3.70 USD | -9.09% |
| 2018 Q2 | 4.07 USD | -20.66% |
| 2018 Q1 | 5.13 USD | 6.65% |
| 2017 Q2 | 3.23 USD | -15.45% |
| 2017 Q3 | 2.90 USD | -10.22% |
| 2017 Q4 | 4.81 USD | 65.86% |
| 2017 FY | - USD | 60.36% |
| 2017 Q1 | 3.82 USD | 172.86% |
| 2016 Q3 | 2.35 USD | -20.88% |
| 2016 Q1 | 2.67 USD | 286.96% |
| 2016 FY | - USD | -4.49% |
| 2016 Q4 | 1.40 USD | -40.43% |
| 2016 Q2 | 2.97 USD | 11.24% |
| 2015 Q4 | 0.69 USD | -72.51% |
| 2015 Q3 | 2.51 USD | -23.24% |
| 2015 Q2 | 3.27 USD | 0.62% |
| 2015 FY | - USD | 2.3% |
| 2015 Q1 | 3.25 USD | 71.05% |
| 2014 FY | - USD | 12.84% |
| 2014 Q4 | 1.90 USD | -18.45% |
| 2014 Q3 | 2.33 USD | -12.41% |
| 2014 Q2 | 2.66 USD | 6.83% |
| 2014 Q1 | 2.49 USD | 369.81% |
| 2013 Q2 | 2.67 USD | -8.56% |
| 2013 FY | - USD | -2.53% |
| 2013 Q4 | 0.53 USD | -76.13% |
| 2013 Q3 | 2.22 USD | -16.85% |
| 2013 Q1 | 2.92 USD | 90.85% |
| 2012 Q2 | 1.96 USD | -24.03% |
| 2012 Q3 | 2.20 USD | 12.24% |
| 2012 Q4 | 1.53 USD | -30.45% |
| 2012 FY | - USD | 11.67% |
| 2012 Q1 | 2.58 USD | 155.45% |
| 2011 Q4 | 1.01 USD | -47.4% |
| 2011 Q3 | 1.92 USD | 0.0% |
| 2011 Q2 | 1.92 USD | -23.51% |
| 2011 Q1 | 2.51 USD | 68.46% |
| 2011 FY | - USD | 2.09% |
| 2010 Q2 | 1.79 USD | -10.05% |
| 2010 Q3 | 1.87 USD | 4.47% |
| 2010 Q4 | 1.49 USD | -20.32% |
| 2010 FY | - USD | -27.58% |
| 2010 Q1 | 1.99 USD | -68.01% |
| 2009 Q4 | 6.22 USD | 301.29% |
| 2009 Q2 | 1.45 USD | 23.93% |
| 2009 Q1 | 1.17 USD | 74.63% |
| 2009 FY | - USD | 111.0% |
| 2009 Q3 | 1.55 USD | 6.9% |
| 2008 Q4 | 0.67 USD | -58.13% |
| 2008 Q2 | 1.44 USD | 33.33% |
| 2008 Q3 | 1.60 USD | 11.11% |
| 2008 Q1 | 1.08 USD | -31.65% |
| 2008 FY | - USD | -11.35% |
| 2007 Q4 | 1.58 USD | 7.48% |
| 2007 Q3 | 1.47 USD | 7.3% |
| 2007 Q2 | 1.37 USD | 7.03% |
| 2007 Q1 | 1.28 USD | -2.29% |
| 2007 FY | - USD | 14.4% |
| 2006 Q4 | 1.31 USD | 0.0% |
| 2006 Q3 | 1.31 USD | 9.17% |
| 2006 Q2 | 1.20 USD | 7.14% |
| 2006 Q1 | 1.12 USD | 12.0% |
| 2006 FY | - USD | 22.33% |
| 2005 Q2 | 0.92 USD | -8.91% |
| 2005 Q3 | 1.05 USD | 14.13% |
| 2005 FY | - USD | 27.94% |
| 2005 Q4 | 1.00 USD | -4.76% |
| 2005 Q1 | 1.01 USD | 236.67% |
| 2004 Q2 | 0.86 USD | 59.26% |
| 2004 Q1 | 0.54 USD | -28.95% |
| 2004 FY | - USD | 12.5% |
| 2004 Q4 | 0.30 USD | -65.52% |
| 2004 Q3 | 0.87 USD | 1.16% |
| 2003 Q3 | 0.71 USD | 10.94% |
| 2003 Q2 | 0.64 USD | -7.25% |
| 2003 FY | - USD | 21.21% |
| 2003 Q4 | 0.76 USD | 7.04% |
| 2003 Q1 | 0.69 USD | 11.29% |
| 2002 Q3 | 0.67 USD | 28.85% |
| 2002 FY | - USD | 39.16% |
| 2002 Q2 | 0.52 USD | 6.12% |
| 2002 Q1 | 0.49 USD | 13.95% |
| 2002 Q4 | 0.62 USD | -7.46% |
| 2001 FY | - USD | 50.91% |
| 2001 Q3 | 0.54 USD | 0.0% |
| 2001 Q4 | 0.43 USD | -20.37% |
| 2000 FY | - USD | 400.0% |
| 1999 FY | - USD | -73.81% |
| 1998 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Phreesia, Inc. | -2.51 USD | 1111.155% |
| Accuray Incorporated | -0.16 USD | 15962.5% |
| Align Technology, Inc. | 5.82 USD | -336.082% |
| AxoGen, Inc. | -0.51 USD | 5076.471% |
| Boston Scientific Corporation | 1.08 USD | -2250.0% |
| CVS Health Corporation | 6.49 USD | -291.063% |
| Cardinal Health, Inc. | 3.48 USD | -629.31% |
| Centene Corporation | 4.97 USD | -410.664% |
| DaVita Inc. | 7.62 USD | -233.071% |
| HCA Healthcare, Inc. | 19.24 USD | -31.913% |
| Hologic, Inc. | 3.35 USD | -657.612% |
| Humana Inc. | 20.09 USD | -26.332% |
| IDEXX Laboratories, Inc. | 10.17 USD | -149.558% |
| Laboratory Corporation of America Holdings | 4.80 USD | -428.75% |
| Masimo Corporation | 1.54 USD | -1548.052% |
| McKesson Corporation | 22.54 USD | -12.6% |
| Patterson Companies, Inc. | 2.00 USD | -1169.0% |
| Quest Diagnostics Incorporated | 7.59 USD | -234.387% |
| ResMed Inc. | 6.94 USD | -265.706% |
| Henry Schein, Inc. | 3.18 USD | -698.113% |
| Teladoc Health, Inc. | -1.36 USD | 1966.176% |
| Universal Health Services, Inc. | 10.35 USD | -145.217% |
| Veeva Systems Inc. | 3.27 USD | -676.147% |
| Baxter International Inc. | 5.25 USD | -383.429% |
| Becton, Dickinson and Company | 5.13 USD | -394.737% |
| Intuitive Surgical, Inc. | 5.12 USD | -395.703% |
| Danaher Corporation | 6.38 USD | -297.806% |
| Stryker Corporation | 8.34 USD | -204.317% |
| Medtronic plc | 2.77 USD | -816.245% |